Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 15 of 15 entries
Sorted by: Best Match Show Resources per page
Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using .

Japanese journal of radiology

Kitajima K, Watabe T, Nakajo M, Ishibashi M, Daisaki H, Soeda F, Tanemura A, Kanekura T, Yamazaki N, Ito K.
PMID: 34287739
Jpn J Radiol. 2022 Jan;40(1):75-85. doi: 10.1007/s11604-021-01174-w. Epub 2021 Jul 21.

OBJECTIVE: In malignant melanoma patients treated with immune checkpoint inhibitor (ICI) therapy, three different FDG-PET criteria, European Organization for Research and Treatment of Cancer (EORTC), PET Response Criteria in Solid Tumors (PERCIST), immunotherapy-modified PERCIST (imPERCIST), were compared regarding response...

Cite
Kitajima K, Watabe T, Nakajo M, et al. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using . Jpn J Radiol. 2021;40(1):75-85doi: 10.1007/s11604-021-01174-w.
Kitajima, K., Watabe, T., Nakajo, M., Ishibashi, M., Daisaki, H., Soeda, F., Tanemura, A., Kanekura, T., Yamazaki, N., & Ito, K. (2022). Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using . Japanese journal of radiology, 40(1), 75-85. https://doi.org/10.1007/s11604-021-01174-w
Kitajima, Kazuhiro, et al. "Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using ." Japanese journal of radiology vol. 40,1 (2022): 75-85. doi: https://doi.org/10.1007/s11604-021-01174-w
Kitajima K, Watabe T, Nakajo M, Ishibashi M, Daisaki H, Soeda F, Tanemura A, Kanekura T, Yamazaki N, Ito K. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using . Jpn J Radiol. 2022 Jan;40(1):75-85. doi: 10.1007/s11604-021-01174-w. Epub 2021 Jul 21. PMID: 34287739.
Copy Download .nbib Format: NLM
Second-line immunotherapy in patients with metastatic melanoma.

The Lancet. Oncology

Wong A, Gyorki DE.
PMID: 33989555
Lancet Oncol. 2021 Jun;22(6):746-748. doi: 10.1016/S1470-2045(21)00190-X. Epub 2021 May 11.

No abstract available.

Cite
Wong A, Gyorki DE. Second-line immunotherapy in patients with metastatic melanoma. Lancet Oncol. 2021;22(6):746-748doi: 10.1016/S1470-2045(21)00190-X.
Wong, A., & Gyorki, D. E. (2021). Second-line immunotherapy in patients with metastatic melanoma. The Lancet. Oncology, 22(6), 746-748. https://doi.org/10.1016/S1470-2045(21)00190-X
Wong, Annie, and Gyorki, David E. "Second-line immunotherapy in patients with metastatic melanoma." The Lancet. Oncology vol. 22,6 (2021): 746-748. doi: https://doi.org/10.1016/S1470-2045(21)00190-X
Wong A, Gyorki DE. Second-line immunotherapy in patients with metastatic melanoma. Lancet Oncol. 2021 Jun;22(6):746-748. doi: 10.1016/S1470-2045(21)00190-X. Epub 2021 May 11. PMID: 33989555.
Copy Download .nbib Format: NLM
Perfusión aislada de extremidad: una opción terapéutica para metástasis en tránsito de melanoma nodular y lentiginoso acral.

Cirugia y cirujanos

Duarte C, Restrepo J, Gómez AP, Carreño A.
PMID: 34352864
Cir Cir. 2021;89(4):469-475. doi: 10.24875/CIRU.20000549.

OBJETIVO: describir la experiencia inicial en Colombia en el manejo del melanoma de extremidad con perfusión aislada y comparar la respuesta de los subtipos histológicos más frecuentes en Colombia con la literatura.MATERIALES Y MÉTODOS: estudio descriptivo, retrospectivo de una...

Cite
Duarte C, Restrepo J, Gómez AP, et al. Isolated limb perfusion: A therapeutic option for nodular and acral lentiginous melanoma. Perfusión aislada de extremidad: una opción terapéutica para metástasis en tránsito de melanoma nodular y lentiginoso acral. Cir Cir. 2021;89(4):469-475doi: 10.24875/CIRU.20000549.
Duarte, C., Restrepo, J., Gómez, A. P., & Carreño, A. (2021). Isolated limb perfusion: A therapeutic option for nodular and acral lentiginous melanoma. Perfusión aislada de extremidad: una opción terapéutica para metástasis en tránsito de melanoma nodular y lentiginoso acral. Cirugia y cirujanos, 89(4), 469-475. https://doi.org/10.24875/CIRU.20000549
Duarte, Carlos, et al. "Isolated limb perfusion: A therapeutic option for nodular and acral lentiginous melanoma." Perfusión aislada de extremidad: una opción terapéutica para metástasis en tránsito de melanoma nodular y lentiginoso acral. Cirugia y cirujanos vol. 89,4 (2021): 469-475. doi: https://doi.org/10.24875/CIRU.20000549
Duarte C, Restrepo J, Gómez AP, Carreño A. Isolated limb perfusion: A therapeutic option for nodular and acral lentiginous melanoma. Perfusión aislada de extremidad: una opción terapéutica para metástasis en tránsito de melanoma nodular y lentiginoso acral. Cir Cir. 2021;89(4):469-475. doi: 10.24875/CIRU.20000549. PMID: 34352864.
Copy Download .nbib Format: NLM
Showing 13 to 15 of 15 entries